Andere Sprachen Krystal Biotech, Inc.

Aktien

A2JH2F

US5011471027

KRYS

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 06.06.2024			% 5 Tage	% 1. Jan.
165,7 ^USD	-1,16 %		+2,52 %	+33,55 %

23.05.	Krystal Biotech Insider verkaufte Aktien im Wert von $3.282.690, laut einer aktuellen SEC Einreichung	MT
14.05.	Transcript : Krystal Biotech, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 02:20 PM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference	05.06.
Krystal Biotech Insider Sold Shares Worth $3,282,690, According to a Recent SEC Filing	23.05.
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference	15.05.
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference	08.05.
Sector Update: Health Care Stocks Gain Pre-Bell Monday	06.05.
Krystal Biotech Swings to Q1 Profit -- Shares Fall	06.05.
Krystal Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06.05.
Earnings Flash (KRYS) KRYSTAL BIOTECH Reports Q1 Revenue $45.3M, vs. Street Est of $47.4M	06.05.
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates	06.05.
Futures Rise Pre-Bell Ahead of Latest Earnings Week; Asia Mostly Up, Europe Strong	06.05.
North American Morning Briefing : Stock Futures -2-	06.05.
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting	02.05.
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024	26.04.
Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung	22.04.
Krystal Biotech, Inc Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung	22.04.
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	05.04.
Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	04.04.
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing	12.03.
Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing	12.03.
Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Krystal Biotech, Inc.

Aktien

A2JH2F

US5011471027

KRYS

Andere Sprachen

Filter